Literature DB >> 2436046

Humoral factors in peripheral nerve disease.

K V Toyka, K Heininger.   

Abstract

Humoral factors including soluble substances transported by the blood stream and factors released at a target tissue may play a role in diseases of the peripheral nervous system. Various criteria have to be met in order to accept humoral factors as potential pathogens. In this review these general criteria are discussed, including the evidence provided by plasma exchange therapy, demonstration of circulating or deposited autoantibodies and immune complexes, identification of antigenic molecules, animal model diseases, passive transfer experiments, and the demonstration of circulating factors not directed against specific targets. In acute, chronic, and chronic relapsing inflammatory polyneuropathies, and in the polyneuropathy associated with monoclonal gammopathy, humoral factors have been identified, but their exact pathogenic role is not fully understood. In the Lambert-Eaton myasthenic syndrome, a disorder of the motor nerve terminal, pathogenic IgG-antibodies have been demonstrated by passive transfer experiments. In the experimental animal model disorders, the acute and chronic variants of experimental allergic neuritis, humoral factors including antibodies to myelin basic proteins and galactocerebroside and nonspecific humoral factors may all contribute to the ultimate peripheral nerve damage, but their relative importance in relation to cell-mediated immune reactions is not yet clear.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436046     DOI: 10.1002/mus.880100305

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Treatment of chronic relapsing inflammatory demyelinating polyneuropathy by cyclosporin A and plasma exchange. A case report.

Authors:  H Hefter; K B Sprenger; G Arendt; D Hafner
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

2.  Spinal cord dysmyelination caused by an antiproteolipid protein IgM antibody: implications for the mechanism of central nervous system myelin formation.

Authors:  J Rosenbluth; R Schiff
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.